Results 61 to 70 of about 27,754 (168)

Hemorrhagic Intestinal Henoch-Schonlein Purpura Complicated by Cytomegalovirus Infection

open access: yesCanadian Journal of Gastroenterology, 1998
A 54-year-old man on hemodialysis for acute chronic renal failure and on corticosteroids for Henoch-Schonlein purpura developed massive hematochezia. After extensive clinical investigation, an ileal bleeding site was identified and surgically removed ...
Phong Nguyen-Ho   +2 more
doaj   +1 more source

Does clinical exposure to different skin tones during training improve diagnostic ability?

open access: yesMedical Education, Volume 60, Issue 4, Page 410-417, April 2026.
Abstract Background Previous studies have shown that medical students demonstrate poorer performance when diagnosing pathology in skin of colour (SOC) compared to white skin (WS); it is important to understand the reasons underpinning this. If not addressed, poorer differential diagnostic ability in certain skin tones could entrench existing racial ...
Yusra Shammoon   +10 more
wiley   +1 more source

Henoch-Schönlein Purpura Developed after Radical Cystectomy [PDF]

open access: yes, 2013
We report a case of Henoch-Schönlein purpura that developed after radical cystectomy. The patient was a 70-year-old man who visited our hospital with a chief complaint of asymptomatic macroscopic hematuria and was diagnosed with invasive bladder cancer ...
伊藤, 悠城   +7 more
core  

Henoch-Schönlein purpura nephritis associated with monoclonal gammopathy of renal significance: a case report

open access: yes, 2019
Monoclonal gammopathy of renal significance (MGRS) can present with different morphologic features and lead to kidney failure. The Henoch-Schönlein purpura nephritis (HSPN) that cannot be relieved by treatment with glucocorticoid and immunosuppressive ...
Jun-yue Huang (7029350)   +5 more
core   +1 more source

Safety of Immune Checkpoint Inhibitors in Cancer Patients With Preexisting Autoimmune Vasculitis

open access: yesACR Open Rheumatology, Volume 8, Issue 3, March 2026.
Objective Immune checkpoint inhibitors (ICIs) are effective cancer therapies but often cause serious immune‐related adverse events (irAEs). Patients with preexisting autoimmune diseases, including vasculitis, are excluded from trials. We aimed to evaluate the frequency, severity, and outcomes of vasculitis flares and irAEs in this population.
Juan Sevillano   +4 more
wiley   +1 more source

Recurrent Henoch Schönlein purpura without renal involvement successfully treated with methotrexate

open access: yes, 2018
PubMedID: 30453828Introduction: Henoch Schönlein purpura is characterised by palpable purpura, abdominal pain, arthritis/arthralgia, often with a self-limiting course.
Balci S.   +6 more
core   +1 more source

Pulmonary haemorrhage and pleural effusion in an elderly patient with Henoch-Schönlein purpura (IgA vasculitis)-: a case report

open access: yesJournal of the Pakistan Medical Association
Henoch-Schönlein purpura (HSP) also known as IgA vasculitis is a systemic small vessel vasculitis mainly affecting the skin, kidneys, joints, and gastrointestinal tract. However, the disease can affect any organ system of the body. The classic tetrad of
Muhammad Tahir   +3 more
doaj   +1 more source

Fractional Microneedling Radiofrequency for Hidradenitis Suppurativa: A Real‐World Retrospective Study Demonstrating Clinical Efficacy and Safety Across Diverse Anatomical Sites

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 3, March 2026.
ABSTRACT Background Hidradenitis suppurativa (HS) remains a therapeutically challenging disease despite expanding research and evolving systemic treatments. Energy‐based modalities, such as fractional microneedling radiofrequency (FMR), are being increasingly explored as novel treatment options.
Ari Safir   +7 more
wiley   +1 more source

Henoch-Schonlein purpura in children

open access: yes, 2013
Henoch-Schönlein purpura is the most common systemic vasculitis of childhood. In the majority of children, the outcome of Henoch-Schönlein purpura is excellent with spontaneous resolution of symptoms and signs.
Trnka, Peter
core   +1 more source

Successful Treatment of Severe Purpura Fulminans With Anakinra

open access: yesPediatric Dermatology, Volume 43, Issue 2, Page 421-424, March/April 2026.
ABSTRACT Purpura fulminans (PF) is a rare, often fatal pediatric condition characterized by intravascular thrombosis and hemorrhagic infarction of the skin. A timely diagnosis and treatment are paramount to prevent the involvement of internal organs, causing disseminated intravascular coagulation and gangrene of the extremities.
Francesco Zulian   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy